Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

QuantumRD Services in China

1 Oct 2012 07:00

RNS Number : 5302N
ViaLogy PLC
01 October 2012
 



ViaLogy to Offer QuantumRD Services in China

 

 

London, UK October 1, 2012. ViaLogy PLC(LSE/AIM: VIY) announces that the company is in exploratory discussions with some of the largest Chinese national oil companies (NOCs) and upstream services providers to deploy QuantumRD® software platform for both their national and global assets.

 

As the world's 4th largest producer, China possesses substantial energy resources that include over 20 billion barrels of oil (14th largest in the world) and 100Tcf of natural gas. China's increasing energy needs coupled with growing emphasis on new discoveries, optimizing primary recovery efficiencies, and cost-effective development of proven fields provide a major opportunity for leveraging QuantumRD capabilities.

 

Some of the key strategic initiatives for Chinese operators include increasing production from mature fields; exploring new offshore areas of Bohai Bay and the South China Sea as well as onshore oil in western interior provinces such as Xinjiang and Inner Mongolia. QuantumRD processing to discover and characterize thin laminates, and delineate reservoirs below seismic resolution in complex tectonic stratigraphy using existing 3-D are seen as particularly attractive to support ongoing programs.

 

ViaLogy is discussing service delivery arrangements whereby QuantumRDsoftware platform can be utilized to determine the locations of new hydrocarbon assets on active fields. QuantumRD®can potentially provide more accurate structural and stratigraphic interpretations of seismic data than is now achievable with industry-standard tools. ViaLogy's software platform broadens the useable seismic spectra for both low and high frequencies, thus extracting porosity, lithology and fluid information from weak signal data normally discarded because it is buried in background noise and is unrecoverable. The technique is a major departure from current industry capabilities in reservoir characterization, and holds the promise of major cost avoidance and discovery of reserves otherwise undetected to increase the success rate of exploratory drilling and hydrocarbon recovery.

 

These business discussions follow issuance of a patent in China for QRI® related technology, which provides the fundamental weak signal processing and computational engine (employing quantum resonance interferometry) for ViaLogy's QuantumRD software platform. The company currently has a number of QuantumRD related patents pending in China.

ViaLogy CEO Robert Dean said, "We are excited by the possibility of applying QuantumRD technology on Chinese prospects, by the business value we could bring to their ongoing exploration and development efforts, and extending their de-risking toolkit for a wide range of conventional and non-conventional formations. We hope to provide the same increases in seismic resolution that we have shown to date with carbonate and sandstone reservoirs in the US and our offshore work in Asia."

Dean added, "We are currently in discussions with potential partners to find the best working structures and business models."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD® platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUBABUPPGMU
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.